ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

MRVI Maravai LifeSciences Holdings Inc

7.30
-0.31 (-4.07%)
After Hours
Last Updated: 17:51:24
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,331,909
Bid Price 7.15
Ask Price 7.50
News -
Day High 7.66

Low
4.52

52 Week Range

High
16.62

Day Low 7.19
Company Name Stock Ticker Symbol Market Type
Maravai LifeSciences Holdings Inc MRVI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.31 -4.07% 7.30 17:51:24
Open Price Low Price High Price Close Price Prev Close
7.58 7.19 7.66 7.30 7.61
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
14,528 1,331,909 $ 7.36 $ 9,800,658 - 4.52 - 16.62
Last Trade Time Type Quantity Stock Price Currency
16:52:58 formt 2,996 $ 7.30 USD

Maravai LifeSciences Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.84B 251.40M - 292.23M -119.03M -0.47 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Maravai LifeSciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No MRVI Message Board. Create One! See More Posts on MRVI Message Board See More Message Board Posts

Historical MRVI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week8.558.617.197.971,578,223-1.25-14.62%
1 Month8.258.927.198.402,249,890-0.95-11.52%
3 Months6.248.925.0457.422,891,3201.0616.99%
6 Months7.228.924.526.652,607,8300.081.11%
1 Year14.0916.624.529.232,643,869-6.79-48.19%
3 Years36.6663.554.5220.871,958,902-29.36-80.09%
5 Years31.1163.554.5221.881,901,416-23.81-76.53%

Maravai LifeSciences Description

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Your Recent History

Delayed Upgrade Clock